Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LULICONAZOLE, with a corresponding US DMF Number 29919.
Remarkably, this DMF maintains an Active status since its submission on October 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 13, 2016, and payment made on November 13, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II